Real‐World Performance of <scp>CSF</scp> Kappa Free Light Chains in the 2024 <scp>McDonald</scp> Criteria
In the setting of the 2024 McDonald criteria, KFLC metrics correcting for the CSF/serum albumin quotient were equivalent to OCBs. The intrathecal fraction provided no advantage over the KFLC index, which is simpler to compute. Importantly, the KFLC index can replace OCB when CSF positivity is essential for diagnosis. We provide an explanation for KFLC's comparable diagnostic performance despite its inability to identify CSF-only clones.
Authors
- M. Bonello
- Stefania Kaninia (ORCID: https://orcid.org/0000-0002-6185-681X)
- Maya Leibowitz
- Victor Iliev
- Will Greenway
- Ryan Cooper (ORCID: https://orcid.org/0000-0002-5473-2392)
- Kathryn Challis
- Ian Galea
- Deborah T. Shode
- Mahmoud Elbahnasawi
- Alison M. E. Whitelegg
- Dominika Gajdasik
Institutions
- Dorset HealthCare University NHS Foundation Trust (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- Thermo Fisher Scientific (United Kingdom) (GB)
- Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust (GB)
- University of Southampton (GB)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1002/acn3.70300
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research